J&P (China) Capital Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

J&P (China) Capital Management’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-78,537	Closed	-$9.73M	–	6
2017 Q3	$9.73M	Hold	78,537	–	–	1.66%	9
2017 Q2	$8.96M	Hold	78,537	–	–	1.89%	8
2017 Q1	$7.31M	Hold	78,537	–	–	2.54%	4
2016 Q4	$7.19M	Hold	78,537	–	–	2.15%	4
2016 Q3	$7.83M	Hold	78,537	–	–	2.14%	6
2016 Q2	$7.02M	Hold	78,537	–	–	2.27%	6
2016 Q1	$6.88M	Hold	78,537	–	–	1.93%	7
2015 Q4	$8.88M	Hold	78,537	–	–	1.95%	9
2015 Q3	$7.96M	Hold	78,537	–	–	1.66%	9
2015 Q2	$9.74M	Hold	78,537	–	–	1.34%	8
2015 Q1	$9.29M	Hold	78,537	–	–	1.31%	11
2014 Q4	$8.01M	Buy	+78,537	New	+$7.67M	0.81%	13

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

J&P (China) Capital Management's FBT Position: Q4 2017 in Review

J&P (China) Capital Management sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q4 2017, closing a stake of 78,537 shares — an estimated $9.73M sold.

J&P (China) Capital Management first reported a position in FBT in Q4 2014 and held it in 12 quarters. The position peaked at $9.74M in Q2 2015. 130 funds tracked by Wall St. Rank hold FBT as of Q4 2017.

J&P (China) Capital Management reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q4 2017 after selling out during the quarter.
J&P (China) Capital Management sold 78,537 First Trust NYSE Arca Biotechnology Index Fund shares in Q4 2017, an estimated $9.73M.
J&P (China) Capital Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2014 and held it in 12 quarters.
J&P (China) Capital Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $9.74M in Q2 2015.
130 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q4 2017.

Based on J&P (China) Capital Management's 13F filing for Q4 2017.